CYTORI THERAPEUTICS INC - COM NEW (CYTX)

CUSIP: 23283K204

Q3 2017 13F Holders as of 30 Sep 2017

Type / Class
Equity / COM NEW
Total 13F shares
2,595,121
Share change
-1,499,124
Total reported value
$950,049
Price per share
$0.37
Number of holders
21
Value change
-$1,749,117
Number of buys
9
Number of sells
9

Quarterly Holders Quick Answers

What is CUSIP 23283K204?
CUSIP 23283K204 identifies CYTX - CYTORI THERAPEUTICS INC - COM NEW in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of CYTORI THERAPEUTICS INC - COM NEW (CYTX) as of Q3 2017

As of 30 Sep 2017, CYTORI THERAPEUTICS INC - COM NEW (CYTX) was held by 21 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 2,595,121 shares. The largest 10 holders included PERKINS CAPITAL MANAGEMENT INC, VANGUARD GROUP INC, BlackRock Inc., GEODE CAPITAL MANAGEMENT, LLC, RENAISSANCE TECHNOLOGIES LLC, Creative Planning, NORTHERN TRUST CORP, UBS Group AG, Bank of New York Mellon Corp, and Virtu Financial LLC. This page lists 21 institutional shareholders reporting positions in this security for the Q3 2017 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.